?

Asia-Pacific Alliance of Liver Diseases , Beijing,APALD

APALD is voluntarily established by Beijing Ditan Hospital Capital Medical University, Peking University First Hospital, Huashan Hospital Fudan University West China Hospital Sichuan University and dozens of hospitals in China, also is jointly established by Beijing Center for Physical and Chemical Analysis, Sunlon Pharmaceutical Co. , Ltd, Beijing Jiahua Yongfang Health Technology Co. , Ltd and dozens of scientific research institutes and companies. It is a non-profit social group which is approved by the Beijing social group registration and administration authority. APALD focuses on industry, medical and research, aims to unite advanced research institutes at home and abroad developing liver disease diagnosis and treatment, the clinical application of new technologies, diagnosis and treatment of liver disease in hospitals, the equipment research of diagnosis and treatment of liver disease by enterprises. From resource integration to joint research, APALD will achieve that the clinical diagnosis and treatment of liver disease and developed technology can replace imported products in China.

bte365国内怎么登陆_bte365绿色页面_bte365 bet

APALD是由首都医科大学附属北京地坛医院、北京大学第一医院、复旦大学附属华山医院和四川大学华西医院等国内数十家医院,北京市理化分析测试中心,森隆药业有限公司、北京嘉华永芳健康科技有限公司等数十家科研院所及企业自愿联合发起成立,是经北京市社会团体登记管理机关核准登记的非营利性社会团体。APALD集产、学、研一体化,宗旨为团结国内外开展肝脏疾病诊断和治疗技术应用研究的高等科研院所,临床应用肝脏病诊断治疗新技术的医院、开展肝脏病诊断治疗设备研制的企业等单位,通过开展资源整合进行联合研究,达到在临床上肝脏疾病诊断和治疗技术与研制出可以替代进口产品的国内肝脏疾病诊断治疗装备之目的。